Dexcom
DXCM · Large Cap · NASDAQ · Healthcare · Medical Devices
$83.49−$1.04 (-1.23%)
Free research brief
Get the full brief on DXCM
Free to track. No card required.
Where DXCM sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$54.11
High$89.98
Today $83.49
RSI (14)
32.8Neutral
03070100
Overall score
78/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$79
Current price
$83.49
Median target
$94
Highest
$115
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
ROIC
Strong · Excellent capital returns
44.5%
ROE
Favorable · 35.6% - strong capital efficiency
38.5%
Debt / equity
Favorable · 0.47 - strong leverage
0.53x
Current ratio
Strong · Good liquidity position
1.73x
⚠ Things to watch
Forward P/E
Needs attention · 19% above avg
31.26x
EV / EBITDA
Rich · Earnings can't support price
23.25x
How it stacks up against its peers
DXCM against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $33.17B | 34.7 | +15.5% | 78 |
 | $10.51B | 20.0 | +19.7% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.08T | 39.1 | +49.6% | 77 |
 | $69.27B | 19.4 | +13.5% | 73 |